Sight Sciences
SGHT

Sight Sciences (SGHT) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
UBSMaintainedBuy$8.00 from $7.00Aug 6, 2026
UBSInitiated CoverageBuy$7.00 from $11.00Jul 28, 2026
CitigroupMaintainedNeutral$6.00 from $5.15Jul 8, 2026
CitigroupMaintainedNeutral$5.15 from $4.35May 28, 2026
CitigroupMaintainedNeutral$6.50 from $9.10Mar 6, 2026
UBSMaintainedBuy$11.00 from $12.00Mar 6, 2026
StifelMaintainedBuy$8.00 from $6.00Mar 2, 2026
Piper SandlerUpgradedNeutral → Overweight$9.00 from $5.00Jan 5, 2026
UBSMaintainedBuy$12.00 from $7.00Dec 23, 2025
CitigroupMaintainedNeutral$9.10 from $5.50Dec 11, 2025
Lake StreetMaintainedBuy$12.00 from $7.00Dec 10, 2025
Morgan StanleyMaintainedEqual-Weight$8.00 from $6.00Dec 2, 2025
Morgan StanleyMaintainedEqual-Weight$6.00 from $4.00Nov 10, 2025
Piper SandlerMaintainedNeutral$5.00 from $4.00Nov 7, 2025
Lake StreetMaintainedBuy$7.00 from $5.00Oct 21, 2025
CitigroupMaintainedNeutral$4.00 from $4.50Oct 7, 2025
NeedhamMaintainedHoldAug 28, 2025
CitigroupMaintainedNeutral$4.50 from $3.60Aug 21, 2025
Lake StreetUpgradedHold → Buy$5.00 from $3.00Aug 8, 2025
Morgan StanleyMaintainedEqual-Weight$4.00 from $3.00Jul 15, 2025

Frequently asked questions

  • What is the latest analyst rating on SGHT?

    On Aug 6, 2026, UBS maintained Sight Sciences at Buy with a price target of $8.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.